Koyfin Home > Directory > Health Care > Antares Pharma > Repurchase of Common Stock

Antares Pharma Repurchase of Common Stock Chart (ATRS)

Antares Pharma annual/quarterly Repurchase of Common Stock from 2003 to 2018.
  • Antares Pharma Repurchase of Common Stock for the quarter ending September 09, 2018 was $0m a 99.93% decrease of 0m year over year
  • Antares Pharma Repurchase of Common Stock for the last 12 months ending September 09, 2018 was $-1m a 54.14% decrease of 0m year over year
  • Antares Pharma Annual Repurchase of Common Stock for 2017 was $0m a 66.27% decrease of 0m from 2016
  • Antares Pharma Annual Repurchase of Common Stock for 2016 was $0m a -4.76% increase of 0m from 2015
  • Antares Pharma Annual Repurchase of Common Stock for 2015 was $0m a -75.45% increase of 0m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Repurchase of Common Stock Data

09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m
12/2016$0m
06/2016$0m
03/2016$0m
09/2015$0m
06/2015$0m

Annual ATRS Repurchase of Common Stock Data

2017$0m
2016$0m
2015$0m
2014$0m
2013$0m
2012$0m
2011$0m